CDK7-IN-2 [CAS 2326428-19-5]
Partner: MedChemexpress LLC
| CAS No: | 2326428-19-5 |
| Applications: | Cancer-Kinase/protease |
| MW: | 497.63 |
| Formula: | C26H39N7O3 |
| SMILES: | O=C(N1CCC(NC2=CC(C)=NC3=C(C(C)C)C=NN23)CC1)O[C@@H]4CN(C(/C=C/CN(C)C)=O)CC4 |
| Purity: | 98.93 |
| Description: | CDK7-IN-2 is a potent inhibitor of CDK7. CDK7 is implicated in both temporal control of the cell cycle and transcriptional activity. CDK7 is implicated in the transcriptional initiation process by phosphorylation of Rbpl subunit of RNA Polymerase II (RNAPII). CDK7 has the potential for the research of cancer disease, in particular aggressive and hard- to-treat cancers (extracted from patent WO2019099298A1, compound 1)[1]. |
| Shipping Conditions: | Ship at ambient |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
